Thereby, glial cell line-derived neurotrophic factor (GDNF) [89,111,125], brain-derived neurotrophic factor (BDNF) [89] and nuclear factor E2-related factor 2 (Nrf2) [112] have been studied for Parkinson’s disease treatment. This evidence concerns the gene BDNF and Parkinson disease.